COPENHAGEN, Denmark, February 1, 2012 /PRNewswire/ --
Pharmaceutical eConsulting (PeC) is investing to remain the chosen partner for electronic regulatory submissions services. Today, the company announced the addition of Shylendra Kumar as Senior Principal Consultant. In this role, Mr. Kumar will contribute, together with Yolanda Hall, to the establishment of innovative consulting services for the life science industry, developing strategies and plans to execute the US business.
Mr. Kumar brings more than 18 years of experience in developing and delivering innovative solutions for the life sciences industry. Prior to joining PeC, he served as President and CEO of Datafarm, Inc., which was one of the leading solutions providers for the life sciences industry. Kumar is an accomplished senior-level executive with expertise in building and managing high-performing teams. He is an innovative thinker with solutions-oriented approach to organize and develop systems and processes in order to drive organizational stability, growth and profitability. Kumar has practical hands-on experience in many aspects of drug development processes, with domain expertise in Regulatory Electronic Submissions and Clinical Data.
Steen Otto Rugaard, CEO and founder at PeC A/S states "Shy was instrumental in creating, selling, and implementing electronic submission solutions for the life sciences industry and this experience gives him the unique ability to provide exceptional leadership and create a culture of high achievement and excellent customer service, while contributing to the overall management and strategic development of our company. Plus, he is one of the best and brightest in the industry, so I am personally thrilled to have him on the PeC team."
"The speed at which PeC has become one of the leading electronic submission services providers in Europe is staggering," said Shy Kumar. "I look forward at the opportunity to extend such unprecedented market leadership world-wide."
PeC is the emerging leader in electronic submissions services for the global life sciences industry. PeC has more than 20 customers, ranging from large pharmaceutical companies to emerging bio-techs. Founded in 2007, PeC is a privately held company headquartered in Copenhagen, Denmark with offices in London and Boston.
For more information, visit http://www.pec-services.com.
Steen Otto Rugaard
SOURCE Pharmaceutical eConsulting